Bone Biologics Corporation / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €1.85M
    R&D expenses
    €1.86M
    EBITDA
    -€4.48M
    D&A
    €40.58K
    EBIT
    -€3.70M
    Interest expenses
    €0.00
    EBT
    -€3.64M
    Tax expenses
    €779.78K
    Net income
    -€3.64M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€3.35K
    Changes in working capital
    €544.57K
    Operating cash flow
    -€2.86M
    Capex
    €4.32
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €4.72M
    Debt repayment
    €0.00
    Other financing cash flow
    €1.86M
    Net financing cash flow
    €6.58M
    Foreign exchange effects
    €0.00
    Net change in cash
    €3.72M
    Cash at end of period
    €5.73M
    Free cash flow
    -€2.86M

    Balance sheet

    Cash and cash equivalents
    €5.73M
    Cash and short-term investments
    €5.73M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €312.20K
    Total current assets
    €6.04M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €6.04M
    Accounts payable
    €0.00
    Short-term debt
    €0.00
    Other current liabilities
    €350.52K
    Total current liabilities
    €350.52K
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €0.00
    Total liabilities
    €350.52K
    Common stock
    €1.45K
    Retained earnings
    -€74.89M
    Other equity
    €0.00
    Total equity
    €5.69M
    Total liabilities and shareholders' equity
    €6.04M

    Company information

    Market capitalization
    €3.26M
    Employees
    2
    Enterprise Value
    €13.31M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -64.0% Much better than peer group: -628.8%
    ROA
    -60.3% Much better than peer group: -18,439.4%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -87.6%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.82M

    Notifications